1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "腺瘤" 116 results
        • 異位胸腺瘤合并單純紅細胞再生障礙性貧血一例

          Release date:2016-09-08 09:14 Export PDF Favorites Scan
        • Relationship Between βCatenin,Adenomatous Polyposis Coli Genes and Tumors

          Objective To discuss the molecular structures and functions of βCatenin and APC (Adenomatous polyposis coli) genes, as well as the roles they played during the carcinogenesis and progression of tumors. MethodsAdvances in molecular biology and oncology of βCatenin and APC genes in recent years has been reviewed. ResultsHigh expression of βCatenin and APC genes was an early event during the carcinogenesis due to the abnormal regulation of βCatenin and APC genes. But on the contrary, the low expression of these two genes was probably associated with the progression of tumors. Moreover, βCatenin and APC genes could also regulate the expression of p53,cmyc genes and cyclin D1. Conclusion βCatenin and APC genes may play a key role during the carcinogenesis and progression of tumors and modulate other oncogen/suppressor gene and factors.

          Release date:2016-08-28 05:11 Export PDF Favorites Scan
        • 胰腺囊性腫瘤4例診治報告

          Release date:2016-08-29 03:24 Export PDF Favorites Scan
        • 96例重癥肌無力患者的外科治療

          目的 總結重癥肌無力(MG)患者的外科治療和圍術期處理經驗,以提高手術療效。 方法 2002年1月至2007年6月,對96例MG患者行胸腺切除加前縱隔脂肪組織清掃術,根據臨床相對記分、服藥量改變及生活能力于術后3個月評估臨床療效。 結果 無圍術期死亡。術后發生MG危象8例(8.3% ),其中術前未服用糖皮質激素6例(18.75%),服用糖皮質激素2例(3.13%),經相應的治療治愈。術后發生其他并發癥9例(9.4%),其中肺部感染7例,切口感染2例,均經相應的治療治愈。隨訪96例,隨訪時間3~18個月,其中32例臨床痊愈,30例基本痊愈,15例顯效,12例好轉,7例無效。 結論 MG患者經內科治療效果不佳或無效時,均應考慮手術治療,無論是否有胸腺增生,特別是對合并有胸腺瘤者,應限期手術。若決定行手術治療,術前除繼續服用抗膽堿酯酶藥物外,口服糖皮質激素15d左右可增加手術安全性,提高手術療效。

          Release date:2016-08-30 06:04 Export PDF Favorites Scan
        • Recent of Advances in the Classification of Thymoma

          The classification of thymoma has always been controversial topil in recent years. It hasn’t been unified because of the morphological diversity of thymoma, the heterogeneity of tumour cells and the lack of simple and effective observation index. With the development of diagnostic technique and oncobiology research, several classification methods have been drawn off, including its World Health Organization(WHO) lassification. We reviewed the main classification and discussed the problems of each classification method and their clinical guiding significamce, summarized the development tendency, methods assist the classification and clinical research of thymoma.

          Release date:2016-08-30 06:05 Export PDF Favorites Scan
        • 眼底檢查在家族性多發性息肉病隨訪觀察中的價值

          Release date:2016-09-02 06:11 Export PDF Favorites Scan
        • 18 例少見肝占位性疾病的診治分析

          目的 總結少見肝占位性病變的診治體會。 方法 回顧性分析 2009 年 6 月至 2016 年 4 月期間遵義醫學院附屬醫院收治的 18 例少見肝占位性病變患者的臨床資料。 結果 18 例患者中,包括肝結核 4 例,肝血管平滑肌脂肪瘤(HAML) 3 例,肝局灶性結節性增生(FNH) 4 例,肝腺瘤 1 例,肝寄生蟲病 6 例,所有患者的影像學圖像均表現為肝占位性病變。4 例肝結核患者經正規抗結核治療好轉出院;2 例肝肺吸蟲病患者接受吡奎酮正規驅蟲治療,隨訪期間無異常;1 例血吸蟲病患者行手術治療后治愈出院,未獲得隨訪;3 例寄生蟲感染患者行手術切除病變部位,隨訪期間無異常;3 例 HAML 患者行手術治療,隨訪期間病情無明顯異常,4 例 FNH 患者行手術治療,2 例隨訪期間未見明顯異常,2 例未獲得隨訪;1 例肝腺瘤患者行手術治療,隨訪無明顯異常。出院后 15 例患者獲訪,隨訪時間 2~6 個月,中位數為 3.5 個月。隨訪期間,除 4 例肝結核患者因抗結核治療引起相應并發癥、經保守治療好轉外,其余患者均未見明顯并發癥發生。 結論 大多數少見肝占位性病變術前診斷較困難,熟悉掌握疾病相關特點及影像學表現,可降低誤診率,但明確診斷主要依靠病理學檢查,治療以手術為主。

          Release date:2017-04-01 08:56 Export PDF Favorites Scan
        • Contrast-enhanced CT-based radiomics nomogram for differentiation of low-risk and high-risk thymomas

          Objective To develop a radiomics nomogram based on contrast-enhanced CT (CECT) for preoperative prediction of high-risk and low-risk thymomas. Methods Clinical data of patients with thymoma who underwent surgical resection and pathological confirmation at Northern Jiangsu People's Hospital from January 2018 to February 2023 were retrospectively analyzed. Feature selection was performed using the Pearson correlation coefficient and least absolute shrinkage and selection operator (LASSO) method. An ExtraTrees classifier was used to construct the radiomics signature model and the radiomics signature. Univariate and multivariable logistic regression was applied to analyze clinical-radiological characteristics and identify variables for developing a clinical model. The radiomics nomogram model was developed by combining the radiomics signature and clinical features. Model performance was evaluated using area under the curve (AUC), sensitivity, specificity, accuracy, negative predictive value, and positive predictive value. Calibration curves and decision curves were plotted to assess model accuracy and clinical values. Results A total of 120 patients including 59 females and 61 males with an average age of 56.30±12.10 years. There were 84 patients in the training group and 36 in the validation group, 62 in the low-risk thymoma group and 58 in the high-risk thymoma group. Radiomics features (1 038 in total) were extracted from the arterial phase of CECT scans, among which 6 radiomics features were used to construct the radiomics signature. The radiomics nomogram model, combining clinical-radiological characteristics and the radiomics signature, achieved an AUC of 0.872 in the training group and 0.833 in the validation group. Decision curve analysis demonstrated better clinical efficacy of the radiomics nomogram than the radiomics signature and clinical model. Conclusion The radiomics nomogram based on CECT showed good diagnostic value in distinguishing high-risk and low-risk thymoma, which may provide a noninvasive and efficient method for clinical decision-making.

          Release date:2024-08-02 10:43 Export PDF Favorites Scan
        • Progress in Thymectomy for the Treatment of Non-thymomatous Myasthenia Gravis

          Thymectomy is a major surgical procedure for patients with non-thymomatous myasthenia gravis,and can enhance their symptomatic remission rate and cure rate. There is still much controversy about appropriate surgical approach and extent of resection of thymectomy. The majority of thoracic surgeons believe that the completeness of thymectomy is closely associated with clinical symptom improvement,and perform complete resection of encapsulated thymus and surroun-ding fat tissues via mid-sternotomy. But minimally invasive thymectomies are often more acceptable by patients. On the contrary,in view of common existence of ectopic thymus tissue,some thoracic surgeons advocate a combination of cervical incision and sternotomy in order to further completely remove all thymus tissue.

          Release date:2016-08-30 05:47 Export PDF Favorites Scan
        • USE OF ARTIFICIAL BONE OF TRICALCIUM PHOPHATE IN SELLAR FLOOR RECONSTRUCTION AFTER TRANSSPHENOIDAL MICROSURGERY FOR PITUITARY ADEOMA

          ObjectiveTo explore the effectiveness of the usage of artificial bone of tricalcium phophate in sellar floor reconstruction after transsphenoidal microsurgery for pituitary adeoma. MethodsBetween January and December 2014, 85 patients with pituitary adema underwent transsphenoidal microsurgery, and the clinical data were retrospectively analyzed. "Sandiwich" was used for sellar floor reconstruction in 46 cases (control group), and "sandiwich" combined with the artificial bone of tricalcium phophate in 39 cases (trial group). There was no significant difference in gender, age, disease duration, size of tumor, invasiveness, and the degree of damage to the sellar floor between 2 groups (P>0.05). ResultsTotal removal and subtotal removal of tumors were achieved in 39 cases and 7 cases of the control group, and in 33 cases and 6 cases of the trial group, showing no significant difference between 2 groups (Z=-1.303, P=0.193). Cerebrospinal leakage occurred in 8 cases of the control group and in 10 cases of the trial group during operation, showing no significant difference (Z=-1.748, P=0.080). The case number of cerebrospinal leakage in the control group (4 cases) was significantly more than that in the trial group (0) after operation (P=0.020). The time of gauze removal in the trial group (3 days) was significant shorter than that in the control group[(4.3±1.6) days] (t=2.236, P=0.033). The patients were followed up 3-14 months in the control group and 5-13 months in the trial group. No cerebrospinal leakage occurred during follow-up. ConclusionSellar floor reconstruction with artificial bone of tricalcium phophate is safe, and it can reduce cerebrospinal leakage and shorten the time of gauze removal.

          Release date: Export PDF Favorites Scan
        12 pages Previous 1 2 3 ... 12 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品